AMANDA BELL: Open Payments
NPI 1487030201 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,215 in 103 payments from 19 companies in 2025. Trend: 2023 $2,450 · 2024 $1,982 · 2025 $2,215
Food & beverage: $2,034Education: $181
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 20 | $344 |
| ABBVIE INC. | 15 | $317 |
| GENZYME CORPORATION | 8 | $260 |
| Janssen Biotech, Inc. | 12 | $258 |
| Regeneron Healthcare Solutions, Inc. | 7 | $208 |
| Novartis Pharmaceuticals Corporation | 10 | $207 |
| REVANCE THERAPEUTICS, INC. | 2 | $158 |
| LEO Pharma Inc. | 4 | $84 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $82 |
| Arcutis Biotherapeutics, Inc. | 4 | $78 |
Products named: DUPIXENT, Bimzelx, TREMFYA, RINVOQ, DAXXIFY, SKYRIZI, COSENTYX, Zoryve.
Industry payments across TX — which companies pay providers there.
